Matt Walz is the CEO of Trialbee, a global leader in technology-driven patient recruitment. He brings more than 20 years of software and leadership experience in the life sciences industry. Matt ...

Gain perspective on how agentic AI can bridge eCOA, EDC, IRT, and CTMS platforms to reduce manual effort and improve ...

Bipolar disorder comes in many distinct forms and genetic differences cause people to respond differently to lithium, paving ...

A groundbreaking Genomic Press interview explores how Dr. Martin Alda transformed worldwide understanding of bipolar disorder ...

Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi were awarded the prize for research showing how the body regulates its ...

Artificial intelligence tools are now used in a variety of different ways in Michigan Medicine’s emergency department, from helping physicians give feedback to detecting patients at higher risk for ...

Emerging technologies, such as functional near-infrared spectroscopy, offer in-office real-time monitoring for potential ...

Scientists on Monday said initial trial results for Pfizer Inc and BioNTech's coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many ...

Experts at ASHG 2025 will tackle clinical and genetic research challenges on sex, gender and sexuality, exploring ethics, ...

This groundbreaking research delves into the enigmatic world of canine slumber, unveiling what dogs are likely dreaming about ...

At Newsweek's Digital Health Care Forum, industry leaders discussed the challenges of seamless data-sharing, including AI ...

Soung also spoke at the 2025 Skin of Color Update, addressing multidisciplinary approaches to treating comorbidities in patients with psoriasis and the role of GLP-1 RAs in treatments. She and another ...